Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moxifloxacin AF for Bacterial Conjunctivitis
NCT00759148Phase 3Completed
- Sponsor
- Alcon Inc.
- Start
- Oct 2008
- Primary completion
- Mar 2010
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of Moxisurge in bacterial conjunctivitis (BC), sponsored by Alcon Inc.. Started Oct 2008; status: completed.
02
Drugs
Moxisurge
03
Conditions
bacterial conjunctivitis (BC)
Beyond the preview
Go deeper on NCT00759148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00759148.